RBBP9 and colitis: Consequently, genetic inhibition of STAT1 or the use of the JAK/STAT inhibitor upadacitinib (UPA) reversed the apoptotic phenotype of Rbbp9-/- organoids and mitigated the enhanced colitis observed in dextran sodium sulfate (DSS)-treated Rbbp9-/- mice.